Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preference for Autoinjector A vs B in RA and PsO
NCT01875991Phase 4Completed
- Sponsor
- Amgen
- Start
- Jun 2013
- Primary completion
- Mar 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), plaque psoriasis, sponsored by Amgen. Started Jun 2013; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)plaque psoriasis
Beyond the preview
Go deeper on NCT01875991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875991.